EE9700326A - Rakuliin analgeetiliste ühendite tootmiseks valu ravimiseks - Google Patents

Rakuliin analgeetiliste ühendite tootmiseks valu ravimiseks

Info

Publication number
EE9700326A
EE9700326A EE9700326A EE9700326A EE9700326A EE 9700326 A EE9700326 A EE 9700326A EE 9700326 A EE9700326 A EE 9700326A EE 9700326 A EE9700326 A EE 9700326A EE 9700326 A EE9700326 A EE 9700326A
Authority
EE
Estonia
Prior art keywords
pain
treatment
production
cell line
analgesic compounds
Prior art date
Application number
EE9700326A
Other languages
English (en)
Estonian (et)
Inventor
Saydoff Joel
Wong Shou
Original Assignee
Cytotherapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytotherapeutics, Inc. filed Critical Cytotherapeutics, Inc.
Publication of EE9700326A publication Critical patent/EE9700326A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EE9700326A 1995-06-07 1996-06-07 Rakuliin analgeetiliste ühendite tootmiseks valu ravimiseks EE9700326A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48191795A 1995-06-07 1995-06-07
PCT/US1996/009629 WO1996040959A1 (en) 1995-06-07 1996-06-07 Cell line producing analgesic compounds for treating pain

Publications (1)

Publication Number Publication Date
EE9700326A true EE9700326A (et) 1998-06-15

Family

ID=23913905

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700326A EE9700326A (et) 1995-06-07 1996-06-07 Rakuliin analgeetiliste ühendite tootmiseks valu ravimiseks

Country Status (20)

Country Link
EP (1) EP0833935A1 (ja)
JP (1) JPH11507530A (ja)
KR (1) KR19990022414A (ja)
CN (1) CN1192246A (ja)
AR (1) AR004494A1 (ja)
AU (1) AU6263696A (ja)
BR (1) BR9608746A (ja)
CA (1) CA2223246A1 (ja)
CZ (1) CZ392497A3 (ja)
EE (1) EE9700326A (ja)
HU (1) HUP9901191A2 (ja)
IL (1) IL122415A0 (ja)
IN (1) IN181898B (ja)
IS (1) IS4628A (ja)
NO (1) NO975545L (ja)
PL (1) PL323867A1 (ja)
SK (1) SK167997A3 (ja)
TR (1) TR199701520T1 (ja)
WO (1) WO1996040959A1 (ja)
ZA (1) ZA964880B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2311282A1 (en) * 1997-11-28 1999-06-10 Medical Research Council Yac vectors
AU6151899A (en) 1998-09-23 2000-04-10 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods of treating chronic pain
US6372489B1 (en) 1998-10-27 2002-04-16 Anticancer, Inc. Method and model for hair pigmentation
AU1324100A (en) * 1998-10-27 2000-05-15 Anticancer, Inc. Method and model for hair pigmentation
US6903244B1 (en) 1999-02-26 2005-06-07 University Of Utah Research Foundation Mice which are +/− or −/− for the elastin gene as models for vascular disease
AU2002952993A0 (en) 2002-11-29 2002-12-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic and diagnostic agents
JP2007516984A (ja) 2003-12-24 2007-06-28 ザ ウォルター アンド エリザ ホール インスティテュート オブ メディカル リサーチ 治療用物質およびそのための用途
JP4980211B2 (ja) 2004-05-12 2012-07-18 ウォルター アンド エリザ ホール インスティテュート オブ メディカル リサーチ 細胞単離方法
CA2613480C (en) 2005-06-24 2015-10-20 The Walter And Eliza Hall Institute Of Medical Research Therapeutic pro-apoptotic bh3-like molecules and methods for generating and/or selecting the same
US9717775B2 (en) 2006-07-18 2017-08-01 University Of Utah Research Foundation Methods for treating pain and screening analgesic compounds
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
WO2014194284A1 (en) 2013-05-31 2014-12-04 Mcintosh J Michael Conotoxin peptides, pharmaceutical compositions and uses thereof
CA3003294A1 (en) 2015-10-27 2017-05-04 The University Of Queensland Modified epha4 and uses thereof
CN107964047B (zh) * 2017-12-18 2018-11-02 哈尔滨工业大学 基于内吗啡肽-1和神经降压素(8-13)的嵌合肽及其合成方法和应用
CN112891337A (zh) * 2021-03-26 2021-06-04 河北医科大学 高良姜素及其衍生物在制备预防和治疗神经系统疾病药物中的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7568094A (en) * 1993-08-12 1995-03-14 Cytotherapeutics, Inc. Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules

Also Published As

Publication number Publication date
PL323867A1 (en) 1998-04-27
NO975545D0 (no) 1997-12-02
BR9608746A (pt) 1999-05-11
NO975545L (no) 1998-02-04
IL122415A0 (en) 1998-06-15
EP0833935A1 (en) 1998-04-08
CZ392497A3 (cs) 1998-12-16
AR004494A1 (es) 1998-12-16
TR199701520T1 (xx) 1998-04-21
CA2223246A1 (en) 1996-12-19
KR19990022414A (ko) 1999-03-25
HUP9901191A2 (hu) 1999-08-30
IS4628A (is) 1997-12-04
SK167997A3 (en) 1998-05-06
AU6263696A (en) 1996-12-30
IN181898B (ja) 1998-10-24
CN1192246A (zh) 1998-09-02
WO1996040959A1 (en) 1996-12-19
JPH11507530A (ja) 1999-07-06
ZA964880B (en) 1997-01-07

Similar Documents

Publication Publication Date Title
EE9800194A (et) Uued valuvaigistava toimega ühendid
NO306235B1 (no) Anvendelse av et legemiddel for behandling av artritt
DE69630305D1 (de) Elektrodenkatheter
EE9700326A (et) Rakuliin analgeetiliste ühendite tootmiseks valu ravimiseks
DK0769017T3 (da) Terapeutiske forbindelser
NO941822D0 (no) Brönnsikt for ökt produksjon
AU5884496A (en) Therapeutic sepsis treatment using antagonists to pthrp
NO975660D0 (no) Anvendelse av benzimidazoler for fremstilling av et medikament for behandling av levkemi
EE9800195A (et) Uudsed analgeetilise toimega ühendid
DE69420609T2 (de) Piroxicam enthaltendes analgetisch-entzündungshemmmendes Pflaster
NO953993D0 (no) Fremgangsmåte for behandling av prosessvann
DE69630073D1 (de) (-)Hydroxycitrat enthaltende Verbindungen mit neuen therapeutischen Wirkungen
DE69606320D1 (de) Bohrlochbehandlungsflüssigkeit
DK0866699T3 (da) Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi
KR960037415U (ko) 전기분해에 의한 분뇨정화장치
EP0776666A3 (en) Analgesic and anti-inflammatory medication
LV11966A (lv) Pretiekaisumu lidzeklis arigai lietosanai
GB9515060D0 (en) Therapeutic heterocyclic compounds
KR940015841U (ko) 폐수처리용 농축기
KR970038990U (ko) 후처리 정화조
SE9504669D0 (sv) Positionerbar behandlingskateter
EE00077U1 (et) BIO-tüüpi reoveepuhasti
GB9521463D0 (en) Therapeutic heterocyclic compounds
GB9515305D0 (en) Therapeutic heterocyclic compounds
GB9509419D0 (en) Therapeutic heterocyclic compounds